Liver Iron Retention Estimated from Utilization of Oral and Intravenous Radioiron in Various Anemias and Hemochromatosis in Humans

Autor: Richard van Wijk, Annelies J. Van Vuren, Joannes J.M. Marx, Eduard J. van Beers
Jazyk: angličtina
Rok vydání: 2020
Předmět:
0301 basic medicine
Male
Administration
Oral

lcsh:Chemistry
0302 clinical medicine
lcsh:QH301-705.5
iron 2
Spectroscopy
iron deficiency 5
Iron Radioisotopes
Anemia
Iron-Deficiency

Chemistry
Transferrin
General Medicine
Iron deficiency
Middle Aged
Computer Science Applications
medicine.anatomical_structure
Liver
030220 oncology & carcinogenesis
Hereditary hemochromatosis
hereditary anemia 4
Administration
Intravenous

Female
Hemochromatosis
Adult
medicine.medical_specialty
Adolescent
Serum Albumin
Human

Anemia
Hemolytic
Congenital

Catalysis
Article
Inorganic Chemistry
03 medical and health sciences
Young Adult
Internal medicine
medicine
Liver iron
Humans
In patient
NTBI 3
Physical and Theoretical Chemistry
Molecular Biology
Aged
Red Cell
Organic Chemistry
hemochromatosis 1
Albumin
medicine.disease
Red blood cell
030104 developmental biology
Endocrinology
lcsh:Biology (General)
lcsh:QD1-999
Case-Control Studies
Zdroj: International Journal of Molecular Sciences
Volume 21
Issue 3
International Journal of Molecular Sciences, Vol 21, Iss 3, p 1077 (2020)
ISSN: 1422-0067
DOI: 10.3390/ijms21031077
Popis: Patients with hereditary hemochromatosis and non-transfusion-dependent hereditary anemia develop predominantly liver iron-overload. We present a unique method allowing quantification of liver iron retention in humans during first-pass of 59Fe-labeled iron through the portal system, using standard ferrokinetic techniques measuring red cell iron uptake after oral and intravenous 59Fe administration. We present data from patients with iron deficiency (ID
N = 47), hereditary hemochromatosis (HH
N = 121) and non-transfusion-dependent hereditary anemia (HA
N = 40). Mean mucosal iron uptake and mucosal iron transfer (±
SD) were elevated in patients with HH (59 ±
18%, 80 ±
15% respectively), HA (65 ±
17%, 74 ±
18%) and ID (84 ±
14%, 94 ±
6%) compared to healthy controls (43 ±
19%, 64 ±
18%) (p <
0.05) resulting in increased iron retention after 14 days compared to healthy controls in all groups (p <
0.01). The fraction of retained iron utilized for red cell production was 0.37 ±
0.17 in untreated HA, 0.55 ±
0.20 in untreated HH and 0.99 ±
0.22 in ID (p <
0.01). Interestingly, compared to red blood cell iron utilization after oral iron administration, red blood cell iron utilization was higher after injection of transferrin-bound iron in HA and HH. Liver iron retention was considerably higher in HH and HA compared to ID. We hypothesize that albumin serves as a scavenger of absorbed Fe(II) for delivering albumin-bound Fe(III) to hepatocytes.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje